HOME >> BIOLOGY >> NEWS
Multicenter study nets new lung tumor-suppressor gene

BOSTON--Collaborating scientists in Boston and North Carolina have found that a particular gene can block key steps of the lung cancer process in mice. The researchers report in the journal Nature that LKB1 is not only a "tumor-suppressor" gene for non-small cell lung cancer in mice, it also may be more powerful than other, better-known suppressors. The study will be published on the journal's Web site on Aug. 5 and later in a print version.

If further research shows LKB1 has a similar effect in human lung cells, it could influence the way non-small cell lung cancer is diagnosed and treated, says the study's senior author, Kwok-Kin Wong, MD, PhD, of Dana-Farber, one of three institutions, along with Massachusetts General Hospital and the University of North Carolina School of Medicine, leading the work. If tumors with LKB1 mutations are found to be especially fast-growing, for example, patients with such tumors might be candidates for more aggressive therapy.

People born with defective versions of LKB1 often develop Peutz-Jeghers syndrome, which is marked by intestinal growths and an increased risk for certain cancers. Non-inherited mutations of the gene have been found in some lung cancers. This suggested that LKB1 normally thwarts tumors from forming. Mutated versions may be unable to act as a brake on cancer.

To find out, the investigators ran a series of experiments in mice with a defective form of a gene called Kras, which drives the formation and growth of lung cancer. They tracked the development of lung cancer in animals with mutated LKB1 and compared it to the experience of animals with abnormalities in either of two well-known tumor-suppressor genes.

They found that while Kras "cooperated" with the mutated tumor-suppressor genes to produce lung cancer, it cooperated even more strongly with mutated LKB1. The LKB1-deficient tumors grew more rapidly and spread more frequently than the others, and comprised all three
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
5-Aug-2007


Page: 1 2

Related biology news :

1. New study warns limited carbon market puts 20 percent of tropical forest at risk
2. Clones on task serve greater good, evolutionary study shows
3. Pollution causes 40 percent of deaths worldwide, study finds
4. A study by the MUHC and McGill University opens a new door to understanding cancer
5. New study suggests Concord grape juice may provide protection against breast cancer
6. Preclinical study links gene to brain aneurysm formation
7. In limiting life span, study finds booming bacteria innocent
8. MIT study: Maturity brings richer memories
9. Chickadee, nutchatch presence in conifers increases tree growth, says CU-Boulder study
10. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
11. New study demonstrates important role of glia in circadian timing

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/3/2018)... ... November 01, 2018 , ... Karius , the leading infectious disease genomics ... human pathogens in pediatric patients. One grant of up to $50,000 will be awarded ... for infectious diseases. In addition to the funding, Karius will cover the cost of ...
(Date:10/31/2018)... ... ... ODSC West 2018, the latest in the largest conference series for learning applied ... more than 200 training sessions and workshops led by the best industry experts in ... the art. , ODSC West 2018 will yet again be the largest applied ...
(Date:10/25/2018)... , ... October 24, 2018 , ... ... office location to accommodate the company’s continued growth and success. This expansion announcement ... annual Sharing Alliance’s “Sharing Conference.” This was the seventh consecutive Sharing Conference for ...
Breaking Biology News(10 mins):
(Date:11/3/2018)... ... 01, 2018 , ... Come to Princeton Nov. 14 and ... Division of Clinical Compliance Evaluation, CDER, FDA will be presenting on using data ... should clinical research industry stakeholders keep in mind when implementing and managing risk-based ...
(Date:10/31/2018)... ... October 30, 2018 , ... The assessment of ... important aspect of experimental biology. Reproducibility of cell-based assays is one of the ... the appropriate assay type, there are many more factors to be considered to ...
(Date:10/24/2018)... ... October 22, 2018 , ... uBiome, the leader ... the Data Science Institute, Stephenson Chair of Data Science, and Professor in the ... board of leading scientists and doctors from around the world, Dr. Bourne will ...
(Date:10/18/2018)... ... ... With rapid technological advances in the fertility field, increasing numbers of women ... a cancer diagnosis requiring chemotherapy or removal of an ovary, most women who freeze ... do not want to get pregnant now but may want to in the future. ...
Breaking Biology Technology:
Cached News: